Buprenorphine Hydrochloride Tablet
Product Images NDC 70518-4570

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Buprenorphine Hydrochloride (NDC 70518-4570). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm1 (Buprenorphine 2mg 70518 4570 00)

This text contains information about a medication in the form of sublingual tablets of Buprenorphine manufactured by Advagen Pharma Limited. The tablets come in a box of 30 and should be stored at 20-25°C. The NDC number is 72888-0182-30, and the lot number and expiry date are also provided. The medication is for prescription only and should be kept out of the reach of children. It has been repackaged by RemedyRepack Inc., located in Indiana, PA. For more information, contact 724-465-8762.*

FDA Label Image

Remedy_label (Remedy Label)

This text includes information about a buprenorphine sublingual tablet manufactured by Advagen Pharma Limited. The tablet has a strength of 2 mg and should be stored at 20-25°C. It is a round white tablet with an up arrow head logo. The lot number and expiration date are provided. The packaging was done by RemedyRepack Inc. located in Indiana, PA.*

FDA Label Image

Ifu-image (Buprenorphine Sublingual Tablets Ifu Image)

FDA Label Image

"image Description" (Buprenorphine Sublingual Tablets Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.